Titre : Carcinome d'Ehrlich

Carcinome d'Ehrlich : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Carcinome d'Ehrlich : Questions médicales les plus fréquentes", "headline": "Carcinome d'Ehrlich : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Carcinome d'Ehrlich : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-02", "dateModified": "2025-01-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Carcinome d'Ehrlich" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs", "url": "https://recherchemedicale.com/mesh/D009369", "about": { "@type": "MedicalCondition", "name": "Tumeurs", "code": { "@type": "MedicalCode", "code": "D009369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04" } } }, "about": { "@type": "MedicalCondition", "name": "Carcinome d'Ehrlich", "alternateName": "Carcinoma, Ehrlich Tumor", "code": { "@type": "MedicalCode", "code": "D002286", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ehab Tousson", "url": "https://recherchemedicale.com/author/Ehab%20Tousson", "affiliation": { "@type": "Organization", "name": "Department of Zoology, Faculty of Science, Tanta University, Tanta, 31527, Egypt." } }, { "@type": "Person", "name": "Nariman K Badr El-Din", "url": "https://recherchemedicale.com/author/Nariman%20K%20Badr%20El-Din", "affiliation": { "@type": "Organization", "name": "Department of Zoology, Faculty of Science, University of Mansoura, Mansoura, Egypt. Electronic address: na_ri_eg@yahoo.com." } }, { "@type": "Person", "name": "Mamdooh Ghoneum", "url": "https://recherchemedicale.com/author/Mamdooh%20Ghoneum", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Drew University of Medicine and Science, Los Angeles, CA 90059, USA." } }, { "@type": "Person", "name": "Mohammed M Al-Gayyar", "url": "https://recherchemedicale.com/author/Mohammed%20M%20Al-Gayyar", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, SAU." } }, { "@type": "Person", "name": "V E Balakin", "url": "https://recherchemedicale.com/author/V%20E%20Balakin", "affiliation": { "@type": "Organization", "name": "Physical-Technical Center, Branch of Lebedev Physical Institute, Russian Academy of Sciences, Protvino, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Preclinical Effects Of Melatonin On The Development Of Ehrlich's Tumor: A Biochemical, Cognitive, And Molecular Approach.", "datePublished": "2023-02-23", "url": "https://recherchemedicale.com/article/36825727", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2174/1574892818666230223160858" } }, { "@type": "ScholarlyArticle", "name": "Influence of halloysite nanotubes on the efficiency of Asparaginase against mice Ehrlich solid carcinoma.", "datePublished": "2022-03-04", "url": "https://recherchemedicale.com/article/35844382", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sjbs.2022.02.058" } }, { "@type": "ScholarlyArticle", "name": "The Nociceptive and Inflammatory Responses Induced by the Ehrlich Solid Tumor Are Changed in Mice Healed of", "datePublished": "2024-05-14", "url": "https://recherchemedicale.com/article/38774541", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2024/3771926" } }, { "@type": "ScholarlyArticle", "name": "Vitamin D3 Inhibits the Viability of Breast Cancer Cells In Vitro and Ehrlich Ascites Carcinomas in Mice by Promoting Apoptosis and Cell Cycle Arrest and by Impeding Tumor Angiogenesis.", "datePublished": "2023-10-02", "url": "https://recherchemedicale.com/article/37835527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers15194833" } }, { "@type": "ScholarlyArticle", "name": "Ehrlich Tumor Induces TRPV1-Dependent Evoked and Non-Evoked Pain-like Behavior in Mice.", "datePublished": "2022-09-15", "url": "https://recherchemedicale.com/article/36138983", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/brainsci12091247" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://recherchemedicale.com/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Carcinome d'Ehrlich", "item": "https://recherchemedicale.com/mesh/D002286" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Carcinome d'Ehrlich - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Carcinome d'Ehrlich", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Carcinome d'Ehrlich", "description": "Comment diagnostiquer le carcinome d'Ehrlich ?\nQuels tests sont utilisés pour le diagnostic ?\nLes marqueurs tumoraux sont-ils utiles ?\nLe diagnostic précoce est-il important ?\nQuels symptômes peuvent indiquer un carcinome d'Ehrlich ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Carcinome d'Ehrlich", "description": "Quels sont les symptômes courants du carcinome d'Ehrlich ?\nLe carcinome d'Ehrlich cause-t-il de la fatigue ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes varient-ils selon les stades ?\nLe carcinome d'Ehrlich provoque-t-il des pertes de poids ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Carcinome d'Ehrlich", "description": "Peut-on prévenir le carcinome d'Ehrlich ?\nQuels facteurs de risque sont associés ?\nL'alimentation joue-t-elle un rôle ?\nLe tabagisme est-il un facteur de risque ?\nL'exercice physique aide-t-il à prévenir le cancer ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Carcinome d'Ehrlich", "description": "Quels traitements sont disponibles pour le carcinome d'Ehrlich ?\nLa chimiothérapie est-elle efficace ?\nLa radiothérapie est-elle utilisée ?\nY a-t-il des traitements expérimentaux ?\nComment le traitement est-il personnalisé ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Carcinome d'Ehrlich", "description": "Quelles complications peuvent survenir ?\nLe carcinome d'Ehrlich peut-il entraîner des métastases ?\nComment gérer les douleurs liées au cancer ?\nLes infections sont-elles une préoccupation ?\nLe traitement peut-il causer des complications ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Carcinome d'Ehrlich", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe mode de vie affecte-t-il le risque ?\nY a-t-il des prédispositions génétiques ?", "url": "https://recherchemedicale.com/mesh/D002286?page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le carcinome d'Ehrlich ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen histopathologique et l'imagerie médicale." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les biopsies, l'imagerie par résonance magnétique et les échographies sont couramment utilisés." } }, { "@type": "Question", "name": "Les marqueurs tumoraux sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs peuvent aider à évaluer la progression de la maladie." } }, { "@type": "Question", "name": "Le diagnostic précoce est-il important ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce améliore les chances de traitement efficace." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un carcinome d'Ehrlich ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs, des masses palpables et des changements cutanés peuvent être des signes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du carcinome d'Ehrlich ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs, des masses, et parfois des saignements." } }, { "@type": "Question", "name": "Le carcinome d'Ehrlich cause-t-il de la fatigue ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue est fréquente en raison de la maladie et des traitements." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les changements cutanés et les douleurs persistantes." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les stades ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent s'aggraver avec l'avancement de la maladie." } }, { "@type": "Question", "name": "Le carcinome d'Ehrlich provoque-t-il des pertes de poids ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des pertes de poids inexpliquées peuvent survenir." } }, { "@type": "Question", "name": "Peut-on prévenir le carcinome d'Ehrlich ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain aide." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des agents cancérigènes et des antécédents familiaux." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de certains cancers, y compris le carcinome." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque connu pour de nombreux cancers." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir le cancer ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs cancers." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le carcinome d'Ehrlich ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chimiothérapie peut réduire la taille des tumeurs et améliorer le pronostic." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour traiter les tumeurs localisées." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des essais cliniques évaluent de nouveaux traitements, y compris l'immunothérapie." } }, { "@type": "Question", "name": "Comment le traitement est-il personnalisé ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est adapté en fonction du stade et des caractéristiques de la tumeur." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la métastase, l'infection et des douleurs chroniques." } }, { "@type": "Question", "name": "Le carcinome d'Ehrlich peut-il entraîner des métastases ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il a une forte capacité à se propager à d'autres organes." } }, { "@type": "Question", "name": "Comment gérer les douleurs liées au cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et des thérapies complémentaires peuvent aider à gérer la douleur." } }, { "@type": "Question", "name": "Les infections sont-elles une préoccupation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent survenir en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Le traitement peut-il causer des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des effets secondaires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'exposition à des agents cancérigènes et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de développer un carcinome augmente avec l'âge." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer augmentent le risque de récidive ou de nouveaux cancers." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et l'alimentation influencent le risque." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines mutations génétiques peuvent augmenter le risque de cancer." } } ] } ] }

Sources (10000 au total)

Preclinical Effects Of Melatonin On The Development Of Ehrlich's Tumor: A Biochemical, Cognitive, And Molecular Approach.

It has already been shown that melatonin is an antitumoral molecule that affects malignant cells via some mechanisms. The benefit played by this hormone on cancer is due to its antioxidant effects.... This study aimed to evaluate the preclinical effects of melatonin in mice with the Ehrlich ascites tumor.... Twenty Balb/ c male mice with Ehrlich tumor were treated with different melatonin doses. Their inflammatory and oxidative stress were accessed by gene expression. Hepatotoxicity and hematological para... Gene expression analyses have shown that only Tnfα and Sod1 were expressed in all groups studied. Only the M-3 group showed increased Tnfα expression compared to the control. All groups treated with m... In animals with Ehrlich´s tumor treated with melatonin, a decrease in oxidative stress, an amelioration in welfare and in cognitive tasks could be observed, even if the treatment has not reduced the s...

Thymoquinone Nanoparticles (TQ-NPs) in Kidney Toxicity Induced by Ehrlich Ascites Carcinoma (EAC): An In Vivo Study.

Cisplatin (Cis) is potent chemotherapy used to treating already many different types of cancer; however, it is found to correlate with nephrotoxicity and other adverse health consequences. Thymoquinon... This investigation examined the efficacy of a new nanoparticle (NP) absorbing TQ in an Ehrlich Ascites Carcinoma (EAC) mice model to address its low solubility, enhance its bioavailability, and protec... Following 4 treatment groups were included in this research: (1) control, (2) EAC, (3) EAC + Cis + Thymoquinone nanoparticle (TQ-NP) treated, and (4) EAC + Cis-treated.... The study revealed that TQ-NP was efficacious in avoiding Cis-induced kidney problems in EAC mice, as well as restoring kidney function and pathology. Thymoquinone nanoparticle considerably reduced Ci... Thymoquinone nanoparticle might be used as a potential drug along with Cis anticancer therapy to reduce nephrotoxicity and other side effects while maintaining Cis anticancer properties....